Wealthcare Advisory Partners’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1
Closed -$4K 629
2022
Q2
$4K Buy
+1
New +$3.09K ﹤0.01% 561

Other funds holding VTAK

Wealthcare Advisory Partners's VTAK Position: Q3 2022 in Review

Wealthcare Advisory Partners sold out of Catheter Precision (VTAK) in Q3 2022, closing a stake of 1 share — an estimated $4K sold.

Wealthcare Advisory Partners first reported a position in VTAK in Q2 2022 and held it in 1 quarter. The position peaked at $4K in Q2 2022. 17 funds tracked by Wall St. Rank hold VTAK as of Q3 2022.

  • Wealthcare Advisory Partners reported no remaining Catheter Precision position as of Q3 2022 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 1 Catheter Precision share in Q3 2022, an estimated $4K.
  • Wealthcare Advisory Partners first reported a position in Catheter Precision in Q2 2022 and held it in 1 quarter.
  • Wealthcare Advisory Partners's Catheter Precision position peaked at $4K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2022.

Based on Wealthcare Advisory Partners's 13F filing for Q3 2022, filed 14 Nov 2022.